ELI LILLY & Co is 121.6x more valuable than CORCEPT THERAPEUTICS INC by market capitalization ($1.070 T vs $8.80 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CORT | LLY |
|---|---|---|
| Market cap | $8.80 B | $1.070 T |
| US-listed rank | #1020 | #10 |
| Revenue (latest FY) | $761.41M | $65.18B |
| Net income (latest FY) | $99.65M | $20.64B |
| Net margin | 13.1% | 31.7% |
| P/E (trailing FY) | 88.3 | 51.8 |
| SEC filings | 1,955 | 989 |
ELI LILLY & Co is 121.6x more valuable than CORCEPT THERAPEUTICS INC by market capitalization ($1.070 T vs $8.80 B).
In their latest fiscal years, CORCEPT THERAPEUTICS INC reported $761.41M in revenue while ELI LILLY & Co reported $65.18B.
Full pages: CORCEPT THERAPEUTICS INC and ELI LILLY & Co, or browse the full rankings.